|Bid||0.00 x 1200|
|Ask||57.50 x 1800|
|Day's range||57.70 - 57.72|
|52-week range||46.48 - 64.21|
|Beta (5Y monthly)||0.19|
|PE ratio (TTM)||106.59|
|Forward dividend & yield||1.40 (2.46%)|
|Ex-dividend date||12 Aug 2021|
|1y target est||68.18|
Yahoo Finance's Anjalee Khemlani details the record-breaking daily COVID-19 deaths as the Omicron wave continues and the beginning of Pfizer and BioNTech's clinical trial for an Omicron vaccine.
The FDA bestows an Orphan Drug status to Ionis' (IONS) investigational medicine, eplontersen, for treating people living with transthyretin-mediated amyloidosis.
APPN, AZN, and GRWG have been added to the Zacks Rank #5 (Strong Sell) List on January 25, 2022